Treating the thyroid in the presence of Graves' ophthalmopathy

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 26, Issue 3, 2012, Pages 313-324

  Hegedüs, Laszlo ^a,b   Bonnema, Steen J ^a,b   Smith, Terry J ^a,c   Brix, Thomas H ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

antithyroid drugs; goiter; Graves' ophthalmopathy; hyperthyroidism; hypothyroidism; quality of life; radioactive iodine; thyroid surgery

Indexed keywords

GLUCOCORTICOID; RADIOACTIVE IODINE; RITUXIMAB; STEROID; THIONAMIDE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR;

AGE; AUTOIMMUNITY; CIGARETTE SMOKING; DISEASE COURSE; ENDOCRINE OPHTHALMOPATHY; ETHNICITY; EUTHYROIDISM; GENDER; GENETIC SUSCEPTIBILITY; GENETICS; GRAVES DISEASE; HUMAN; META ANALYSIS; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SEX; SMOKING; THYROID FUNCTION; THYROIDECTOMY;

ANTITHYROID AGENTS; GRAVES OPHTHALMOPATHY; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; THYROID GLAND; THYROIDECTOMY;

EID: 84861566332     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2011.09.005     Document Type: Review

References (83)

1. T. Watt, M. Gronvold, and A.K. Rasmussen Quality of life in patients with benign thyroid disorders. A review European Journal of Endocrinology 154 2006 501 510
2. T. Watt, L. Hegedüs, and A.K. Rasmussen Which domains of thyroid-related quality of life are most relevant? Patients and clinicians provide complementary perspectives Thyroid 17 2007 647 654 (Pubitemid 47311554)
3. M. Abraham-Nordling, G. Wallin, and F. Traisk Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine European Journal of Endocrinology 163 2010 651 657
4. S. Estcourt, A.G. Quinn, and B. Vaidya Quality of life in thyroid eye disease: impact of quality of care European Journal of Endocrinology 164 2011 649 655
5. L. Bartalena, and M.L. Tanda Clinical practice. Graves' ophthalmopathy The New England Journal of Medicine 360 2009 994 1001
6. P. Perros, A.L. Crombie, and P. Kendall-Taylor Natural history of thyroid associated ophthalmopathy Clinical Endocrinology (Oxford) 42 1995 45 50
7. M.F. Prummel, W.M. Wiersinga, and M.P. Mourits Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy The Archives of Internal Medicine 150 1990 1098 1101 (Pubitemid 20155338)
8. T. Bednarczuk, B. Gopinath, R. Ploski, and J.R. Wall Susceptibility genes in Graves ophthalmopathy: searching for a needle in a haystack? Clinical Endocrinology (Oxford) 67 2007 3 19 (Pubitemid 46955456)
9. T.H. Brix, K.O. Kyvik, K. Christensen, and L. Hegedüs Evidence for a major role of heredity in Graves' disease: a population- based study of two Danish twin cohorts Journal of Clinical Endocrinology and Metabolism 86 2001 930 934 (Pubitemid 32207518)
10. Y. Tomer Genetic susceptibility to autoimmune thyroid disease: past, present, and future Thyroid 20 2010 715 725
11. T.H. Brix, G.P. Knudsen, and M. Kristiansen High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity Journal of Clinical Endocrinology and Metabolism 90 2005 5949 5953 (Pubitemid 41606510)
12. T.H. Brix, and L. Hegedüs Twins as a tool for evaluating the influence of genetic susceptibility in thyroid autoimmunity Annals of Endocrinology (Paris) 72 2011 103 107
13. L. Hegedüs, T.H. Brix, and P. Vestergaard Relationship between cigarette smoking and Graves' ophthalmopathy The Journal of Endocrinological Investigation 27 2004 265 271 (Pubitemid 38607480)
14. P. Laurberg, C. Cerqueira, and L. Ovesen Iodine intake as a determinant of thyroid disorders in populations Best Practice & Research: Clinical Endocrinology & Metabolism 24 2010 13 27
15. N. Manji, J.D. Carr-Smith, and K. Boelaert Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype Journal of Clinical Endocrinology and Metabolism 91 2006 4873 4880 (Pubitemid 44917321)
16. L. Bartalena The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy Journal of Clinical Endocrinology and Metabolism 96 2011 592 599
17. L. Hegedüs, and T.J. Smith Douglas RS & Nielsen CH. Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab Clinical Endocrinology (Oxford) 74 2011 1 8
18. G.A. Brent Clinical practice. Graves' disease The New England Journal of Medicine 358 2008 2594 2605
19. L. Hegedüs Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities Endocrinology and metabolism clinics of North America 38 2009 355 371
20. M.N. Stan, and R.S. Bahn Risk factors for development or deterioration of Graves' ophthalmopathy Thyroid 20 2010 777 783
21. S.L. Lim, A.K. Lim, and M. Mumtaz Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease Thyroid 18 2008 1297 1301
22. M. Tellez, J. Cooper, and C. Edmonds Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin Clinical Endocrinology (Oxford) 36 1992 291 294
23. R.S. Bahn Graves' ophthalmopathy The New England Journal of Medicine 362 2010 726 738
24. E. Hagg, and K. Asplund Is endocrine ophthalmopathy related to smoking? British Medical Journal. Clinical research ed 295 1987 634 635 (Pubitemid 17129862)
25. J. Thornton, S.P. Kelly, R.A. Harrison, and R. Edwards Cigarette smoking and thyroid eye disease: a systematic review Eye (London) 21 2007 1135 1145 (Pubitemid 47382137)
26. L. Bartalena, L. Baldeschi, and A. Dickinson Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO European Journal of Endocrinology 158 2008 273 285 (Pubitemid 351404990)
27. R.S. Bahn, H.B. Burch, and D.S. Cooper Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists Thyroid 21 2011 593 646
28. L. Tallstedt, G. Lundell, and O. Torring Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group The New England Journal of Medicine 326 1992 1733 1738
29. A.W. Kung, C.C. Yau, and A. Cheng The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole Journal of Clinical Endocrinology and Metabolism 79 1994 542 546 (Pubitemid 24256550)
30. L.J. DeGroot, A. Mangklabruks, and M. McCormick Comparison of RA 131I treatment protocols for Graves' disease Journal of endocrinological investigation 13 1990 111 118 (Pubitemid 20111825)
31. L. Tallstedt, G. Lundell, H. Blomgren, and J. Bring Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? European Journal of Endocrinology 130 1994 494 497 (Pubitemid 24165777)
32. R.S. Bahn, C.M. Dutton, and N. Natt Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy Journal of Clinical Endocrinology and Metabolism 83 1998 998 1002 (Pubitemid 28496482)
33. I.M. Wakelkamp, O. Bakker, and L. Baldeschi TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients Clinical Endocrinology (Oxford) 58 2003 280 287 (Pubitemid 36308115)
34. D.H. Khoo, S.C. Ho, and L.L. Seah The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy Thyroid 9 1999 1175 1180 (Pubitemid 30038925)
35. S.Y. Goh, S.C. Ho, and L.L. Seah Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease Clinical Endocrinology (Oxford) 60 2004 600 607 (Pubitemid 38669850)
36. J.Y. Noh, N. Hamada, and Y. Inoue Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease Thyroid 10 2000 809 813
37. M.N. Gerding, J.W. van der Meer, and M. Broenink Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy Clinical Endocrinology (Oxford) 52 2000 267 271 (Pubitemid 30169681)
38. M.F. Prummel, W.M. Wiersinga, and M.P. Mourits Amelioration of eye changes of Graves' ophthalmopathy by achieving euthyroidism Acta Endocrinologica 121 1989 185 189 (Pubitemid 20034843)
39. L. Wartofsky, D. Glinoer, and B. Solomon Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States Thyroid 1 1991 129 135
40. P. Abraham, A. Avenell, and C.M. Park A systematic review of drug therapy for Graves' hyperthyroidism European Journal of Endocrinology 153 2005 489 498 (Pubitemid 41556274)
41. L. Bartalena, C. Marcocci, and F. Bogazzi Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy The New England Journal of Medicine 338 1998 73 78 (Pubitemid 28042269)
42. P. Laurberg, G. Wallin, and L. Tallstedt TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study European Journal of Endocrinology 158 2008 69 75 (Pubitemid 351211042)
43. D.S. Ross Radioiodine therapy for hyperthyroidism The New England Journal of Medicine 364 2011 542 550
44. B. Nygaard, L. Hegedüs, and M. Gervil Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease Journal of Internal Medicine 238 1995 491 497
45. Brandt F, Green A, Hegedüs L & Brix T. Is the association between overt hyperthyroidism and mortality causal? Critical review and meta-analysis. European Journal of Endocrinology, in press.
46. M. Vanderpump Cardiovascular and cancer mortality after radioiodine treatment of hyperthyroidism Journal of Clinical Endocrinology and Metabolism 92 2007 2033 2035 (Pubitemid 46997095)
47. S.H. Acharya, A. Avenell, and S. Philip Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review Clinical Endocrinology (Oxford) 69 2008 943 950
48. F. Träisk, L. Tallstedt, and M. Abraham-Nordling Thyroid-Associated Ophthalmopathy after Treatment for Graves' Hyperthyroidism with Antithyroid Drugs or Iodine-131 Journal of Clinical Endocrinology and Metabolism 94 2009 3700 3707
49. A.K. Eckstein, M. Plicht, and H. Lax Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease Journal of Clinical Endocrinology and Metabolism 91 2006 3464 3470 (Pubitemid 44402120)
50. S.J. Bonnema, F.N. Bennedbæk, and J. Gram Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial European Journal of Endocrinology 149 2003 485 492 (Pubitemid 38063062)
51. A.E. Jarlov, L. Hegedüs, and LO Kristensen Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clinical Endocrinology (Oxford) 43 1995 325 329
52. L. Bartalena, C. Marcocci, and F. Bogazzi Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism The New England Journal of Medicine 321 1989 1349 1352 (Pubitemid 19284190)
53. A. Lai, L. Sassi, and E. Compri Lower Dose Prednisone Prevents Radioiodine-Associated Exacerbation of Initially Mild or Absent Graves' Orbitopathy: A Retrospective Cohort Study Journal of Clinical Endocrinology and Metabolism 95 2010 1333 1337
54. B.E. Jensen, S.J. Bonnema, and L. Hegedüs Glucocorticoids do not influence the effect of radioiodine therapy in Graves' disease European Journal of Endocrinology 153 2005 15 21 (Pubitemid 41030512)
55. G. Pellegriti, A. Belfiore, and D. Giuffrida Outcome of differentiated thyroid cancer in Graves' patients Journal of Clinical Endocrinology and Metabolism 83 1998 2805 2809 (Pubitemid 28493780)
56. P. Stalberg, A. Svensson, and O. Hessman Surgical treatment of Graves' disease: evidence-based approach World Journal of Surgery 32 2008 1269 1277
57. T.K. Palit, C.C. Miller 3rd, and D.M. Miltenburg The efficacy of thyroidectomy for Graves' disease: A meta-analysis The Journal of Surgical Research 90 2000 161 165 (Pubitemid 30314455)
58. C. Marcocci, G. Bruno-Bossio, and L. Manetti The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study Clinical Endocrinology (Oxford) 51 1999 503 508 (Pubitemid 29513319)
59. J. Witte, P.E. Goretzki, and C. Dotzenrath Surgery for Graves' disease: total versus subtotal thyroidectomy- results of a prospective randomized trial World Journal of Surgery 24 2000 1303 1311
60. J. Jarhult, C. Rudberg, and E. Larsson Graves' disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection Thyroid 15 2005 1157 1164 (Pubitemid 41720722)
61. L. Chiovato, F. Latrofa, and L.E. Braverman Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens Annals of Internal Medicine 139 2003 346 351
62. M. Moleti, F. Mattina, and I. Salamone Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of graves' ophthalmopathy Thyroid 13 2003 653 658 (Pubitemid 36993561)
63. L.J. DeGroot, and Y. Benjasuratwong Evaluation of thyroid ablative therapy for ophthalmopathy of Graves' disease Orbit 15 1996 187 196 (Pubitemid 26292640)
64. F. Menconi, M. Marino, and A. Pinchera Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids Journal of Clinical Endocrinology and Metabolism 92 2007 1653 1658 (Pubitemid 46997167)
65. J.P. Banga, C.H. Nielsen, and J.A. Gilbert Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trials Thyroid 18 2008 973 981
66. D. El Fassi, C.H. Nielsen, H.C. Hasselbalch, and L. Hegedüs Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion Thyroid 16 2006 709 710
67. M. Salvi, G. Vannucchi, and I. Campi Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression European Journal of Endocrinology 154 2006 511 517
68. D. El Fassi, C.H. Nielsen, and S.J. Bonnema B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study Journal of Clinical Endocrinology and Metabolism 92 2007 1769 1772 (Pubitemid 46997186)
69. M. Salvi, G. Vannucchi, and I. Campi Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study European Journal of Endocrinology 156 2007 33 40 (Pubitemid 46553901)
70. K.A. Heemstra, R.E. Toes, and J. Sepers Rituximab in relapsing Graves' disease, a phase II study European Journal of Endocrinology 159 2008 609 615
71. D. Khanna, K.K. Chong, and N.F. Afifiyan Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy Ophthalmology 117 2010 133 139
72. R.Z. Silkiss, A. Reier, M. Coleman, and S.A. Lauer Rituximab for thyroid eye disease Ophthalmic Plastic and Reconstructive Surgery 26 2010 310 314
73. D. El Fassi, J.P. Banga, and J.A. Gilbert Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies Clinical Immunology 130 2009 252 258
74. S.D. Lytton, K.A. Ponto, and M. Kanitz A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy Journal of Clinical Endocrinology and Metabolism 95 2010 2123 2131
75. R.S. Douglas, A. Tsirbas, and M. Gordon Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique The Archives of Ophthalmology 127 2009 1155 1160
76. M.P. Mourits, M.F. Prummel, W.M. Wiersinga, and L. Koornneef Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy Clinical Endocrinology (Oxford) 47 1997 9 14 (Pubitemid 27313981)
77. G.E. Krassas, A. Stafilidou, and K.G. Boboridis Failure of rituximab treatment in a case of severe thyroid ophthalmopathy unresponsive to steroids Clinical Endocrinology (Oxford) 72 2010 853 855
78. D. El Fassi, C.H. Nielsen, and J. Kjeldsen Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease Gut 57 2008 714 715 (Pubitemid 351579988)
79. D. El Fassi, C.H. Nielsen, and P. Junker Systemic adverse events following rituximab therapy in patients with Graves' disease Journal of Endocrinological Investigation 34 2010 e163 e167
80. J.H. Lazarus, L. Bartalena, and C. Marcocci Glucocorticoid administration for Graves' hyperthyroidism treated by radioiodine - a questionnaire survey among members of the European Thyroid Association Journal of Endocrinological Investigation 33 2010 409 413
81. P. Laurberg, D.C. Berman, S. Andersen, and I.B. Pedersen Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy Thyroid 21 2011 951 956
82. L. Elbers, M. Mourits, and W. Wiersinga Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy Thyroid 21 2011 279 283
83. C. Marcocci, G.J. Kahaly, and G.E. Krassas Selenium and the course of mild Graves' orbitopathy The New England Journal of Medicine 364 2011 1920 1931